Your AI-Trained Oncology Knowledge Connection!

Supplements and Featured Publications

home / publications / supplements

Exploring Further Avenues for Menin Inhibition in Acute Myeloid Leukemia

Volume: 1

Issue: 1

View Issue

Navigating Pediatric-Inspired Regimens in Acute Lymphoblastic Leukemia

Volume: 1

Issue: 1

View Issue

Gaining Insight Into Treatment Personalization in GIST

Volume: 1

Issue: 1

View Issue

Data Informing Treatment Decisions and Strategies in HER2+ Breast Cancer

Volume: 1

Issue: 1

View Issue

$Targeting PRAME in PD-1–Refractory Melanoma$

Targeting PRAME in PD-1–Refractory Melanoma

Volume: 1

Issue: 1

View Issue

Unpacking Pivotal Data Updates in Metastatic Breast Cancer Management

Volume: 1

Issue: 1

View Issue

Navigating Novel Endocrine Therapies in ER+ Breast Cancer

Volume: 1

Issue: 1

View Issue

Going Beyond Immunotherapy in HPV-Negative Head and Neck Squamous Cell Carcinoma

Volume: 1

Issue: 1

View Issue

Addressing Treatment Adherence With Liquid Drug Formulations in CML and ALL

Volume: 1

Issue: 1

View Issue

Dissecting Emerging Data in Metastatic Breast Cancer

Volume: 1

Issue: 1

View Issue

Broadening Awareness Around DLL3-Directed Therapies in Small Cell Lung Cancer and Neuroendocrine Carcinomas

Volume: 1

Issue: 1

View Issue

Targeting c-MET in Advanced Non–Small Cell Lung Cancer

Volume: 1

Issue: 1

View Issue

Diving Into Therapeutic Decision-Making in Later-Line CLL

Volume: 1

Issue: 1

View Issue

Molecular Testing and Evolving Treatment Strategies in HR+/HER2– Advanced Breast Cancer

Volume: 1

Issue: 1

View Issue

The Evolution of Molecular Testing and Targeted Therapy in HR+/HER2– Breast Cancer

Volume: 1

Issue: 1

View Issue

Treatment Considerations and Evolving Data in Advanced Melanoma After Checkpoint Inhibition

Volume: 1

Issue: 1

View Issue

State of the Science Summit Recaps

Volume: 1

Issue: 1

View Issue

Furthering Treatment With Novel Therapies and Multidisciplinary Care in Advanced Melanoma After PD-1 Inhibition

Volume: 01

Issue: 01

View Issue

Therapeutic Advances and AE Management in NF1-Associated Plexiform Neurofibromas

Volume: 1

Issue: 1

View Issue

FLT3 Inhibition Fuels Improved Outcomes in Newly Diagnosed FLT3-ITD–Negative AML

Volume: 1

Issue: 1

View Issue

Defining Frontline Treatment Considerations in Advanced Urothelial Carcinoma

Volume: 1

Issue: 1

View Issue

Moving the Needle With Checkpoint Inhibition in MCC and SCAC

Volume: 1

Issue: 1

View Issue

2025 Genitourinary Cancers Symposium Priority Report

Volume: 1

Issue: 1

View Issue

Perspectives on FDA Oncology Approvals and Withdrawals That Shaped 2024: A Year in Review Roundup

Volume: 1

Issue: 1

View Issue

Treatment Trends in Adult and Pediatric Acute Lymphoblastic Leukemia

Volume: 1

Issue: 1

View Issue

Bridging the Gaps With Bispecific Antibody Therapy in NSCLC

Volume: 1

Issue: 1

View Issue

Treatment Trends and Ongoing Research in Acute Lymphoblastic Leukemia

Volume: 1

Issue: 1

View Issue

Moving the Needle With JAK Inhibition in Myelofibrosis

Volume: 1

Issue: 1

View Issue

Menin Inhibition Makes Waves for KMT2A-Rearranged AML

Volume: 1

Issue: 1

View Issue

Integrating MDM2 Inhibition Into Myelofibrosis Management

Volume: 1

Issue: 1

View Issue

1 2 3 4 5 6 7 >

Latest Conference Coverage

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

BGB-16673 Displays a High ORR and Tolerability in Waldenström Macroglobulinemia

GI Cancer Experts on Notable Updates Shared During the 2025 ASCO Annual Meeting

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512